Primary record
{[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-{[(2S,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]oxy}-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid
- 库存
- 4,825 克
- 纯度
- 99.0 %
- CAS
- 15720-01-1
化合物标识与属性
- CAS
- 15720-01-1
- PubChem CID
- 3080702
- SMILES
- C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)O)O)O)N
- Canonical SMILES
- Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O
名称与同义词
- iso-ADP-ribose
- phosphoribosyl-AMP
- Ado(P)-Rib-P
- AC1MIVJF
- PR-AMP
- 2-(5''-Phosphoribosyl)-5'-amp
- RefChem:908442
- 2'-(5-phosphoribosyl)-5'-AMP
- Epitope ID:191108
- CHEBI:76110
- DTXSID50166226
- Ribosyladenosine 5',5''-bis(phosphate)
- DTXCID4088717
- SCHEMBL29496215
- C15H23N5O14P2
- 2'-(5''-Phosphoribosyl)-5'-adenosine monophosphate
- 15720-01-1
- CID3080702
- C15-H23-N5-O14-P2
- J1.314.049I
- 2'-(5-phosphoribosyl)adenosine 5'-monophosphate
- 2 -(5 -Phosphoribosyl)-5 -AMP
- 2'-(1"-ribosyl)adenosine 5',5"-bis(phosphate)
- 2'-(5"-phosphoribosyl)adenosine 5'-monophosphate
- 2/'-(5/'/'-Phosphoribosyl)-5/'-adenosine monophosphate
- 2'-O-(5-O-phosphono-beta-D-ribofuranosyl)-5'-adenylic acid
- 2'-O-[(5'-PHOSPHO)RIBOSYL]ADENOSINE-5'-MONOPHOSPHATE
- Q27145757
- [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]oxy-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate
- 2'-O-(5-O-phosphono-beta-D-ribofuranosyl)adenosine 5'-(dihydrogen phosphate)
- 5'-Adenylic acid, 2'-O-(5-O-phosphono-beta-D-ribofuranosyl)-
- 2 -O-(5-O-Phosphono-beta-D-ribofuranosyl)-5 -adenylic acid
- O(2')-(O(5')-phosphono-beta-D-ribofuranosyl)-[5']adenylic acid
- 2 -O-(5-O-Phosphono-beta-D-ribofuranosyl)adenosine 5 -phosphoric acid
- Adenosine, 2'-O-(5-O-phosphono-|A-D-ribofuranosyl)-, 5'-(dihydrogen phosphate)
- {[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-{[(2S,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]oxy}-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid
- 11045-18-4
- RIA